Skip to main content
Log in

Lightening the Lupus Load

Emerging Therapies for Systemic Lupus Erythrematosus

  • Emerging Technology
  • Published:
Pharmaceutical & Diagnostic Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

Notes

  1. Alleviate Lupus Affliction with Epratuzumab and Validate its Autoimmune Safety and Efficacy.

References

  1. Ginzler EM, Dooley MA, Aranow C, et al. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. N Engl J Med 2005; 353 (21): 2219–28

    Article  PubMed  CAS  Google Scholar 

  2. Garcia BA, Busby SA, Shabanowitz J, et al. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. J Proteome Res 2005; ASAP Web Release Date: 5 Nov 2005

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lightening the Lupus Load. Pharmaceutical & Diagnostic Innovation 3, 7–10 (2005). https://doi.org/10.1007/BF03257021

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03257021

Keywords

Navigation